Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Humana Inc. (NYSE:HUM). In a filing disclosed on September 12th, the Representative disclosed that they had bought between $1,001 and $15,000 in Humana stock on August 5th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Purchased $1,001 - $15,000 in shares of Semtech NASDAQ: SMTC on 9/2/2025.
- Sold $1,001 - $15,000 in shares of Chart Industries NYSE: GTLS on 9/2/2025.
- Purchased $1,001 - $15,000 in shares of Avient NYSE: AVNT on 9/2/2025.
- Sold $1,001 - $15,000 in shares of Amdocs NASDAQ: DOX on 8/27/2025.
- Sold $1,001 - $15,000 in shares of Amdocs NASDAQ: DOX on 8/26/2025.
- Purchased $1,001 - $15,000 in shares of Intapp NASDAQ: INTA on 8/26/2025.
- Purchased $1,001 - $15,000 in shares of APi Group NYSE: APG on 8/26/2025.
- Purchased $1,001 - $15,000 in shares of Waters NYSE: WAT on 8/26/2025.
- Purchased $1,001 - $15,000 in shares of Semtech NASDAQ: SMTC on 8/26/2025.
- Sold $1,001 - $15,000 in shares of Fortive NYSE: FTV on 8/26/2025.
Humana Stock Performance
NYSE:HUM traded down $3.38 during trading hours on Tuesday, reaching $272.04. The company had a trading volume of 2,637,143 shares, compared to its average volume of 1,735,820. The firm's 50 day moving average price is $266.10 and its 200-day moving average price is $257.19. The firm has a market cap of $32.72 billion, a price-to-earnings ratio of 20.88, a PEG ratio of 1.62 and a beta of 0.44. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $324.38. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69.
Humana (NYSE:HUM - Get Free Report) last released its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The firm had revenue of $32.39 billion for the quarter, compared to analysts' expectations of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The firm's quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter last year, the firm posted $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. On average, analysts forecast that Humana Inc. will post 16.47 EPS for the current year.
Humana Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date of this dividend is Friday, September 26th. Humana's payout ratio is 27.17%.
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in the business. Orion Porfolio Solutions LLC raised its position in Humana by 3.6% in the 2nd quarter. Orion Porfolio Solutions LLC now owns 6,979 shares of the insurance provider's stock valued at $1,706,000 after purchasing an additional 241 shares during the last quarter. B. Riley Wealth Advisors Inc. acquired a new stake in shares of Humana in the 2nd quarter worth $201,000. State of Wyoming lifted its stake in shares of Humana by 391.5% in the second quarter. State of Wyoming now owns 4,178 shares of the insurance provider's stock valued at $1,021,000 after purchasing an additional 3,328 shares during the period. Pitcairn Co. lifted its stake in shares of Humana by 75.2% in the second quarter. Pitcairn Co. now owns 1,777 shares of the insurance provider's stock valued at $434,000 after purchasing an additional 763 shares during the period. Finally, Geneos Wealth Management Inc. increased its holdings in Humana by 40.3% during the 2nd quarter. Geneos Wealth Management Inc. now owns 571 shares of the insurance provider's stock valued at $140,000 after acquiring an additional 164 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.
Analyst Ratings Changes
HUM has been the topic of a number of research reports. Barclays boosted their target price on shares of Humana from $275.00 to $315.00 and gave the stock an "equal weight" rating in a report on Friday, September 5th. Sanford C. Bernstein boosted their price objective on shares of Humana from $269.00 to $341.00 and gave the company an "outperform" rating in a research report on Friday, September 5th. Wall Street Zen cut shares of Humana from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. Piper Sandler lowered their price target on shares of Humana from $288.00 to $272.00 and set a "neutral" rating for the company in a research report on Thursday, July 31st. Finally, Royal Bank Of Canada increased their target price on shares of Humana from $283.00 to $322.00 and gave the company an "outperform" rating in a research report on Thursday, August 21st. Seven analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $289.24.
Get Our Latest Stock Report on HUM
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
Humana Company Profile
(
Get Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.